Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Curative

Explore full profile

Health insurance rebuilt: zero out-of-pocket care with AI-powered simplicity

Austin, United StatesFounded 2020Fintech
Valuation $1–2.5B Last recorded · 2025
Revenue $500M–1B Latest reported FY
Headcount 1–2k Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Curative and the history behind them.

About Curative

Curative is a leader in on-demand public health service programs and infrastructure development. From rapid, mass-scale testing and vaccines for COVID-19 to other essential services, Curative partners with communities to strengthen public health services with turn-key programs, easy-to-access experiences, and scalable infrastructure, keeping people everywhere safe, healthy, and informed. Co-founded by CEO Fred Turner and comprised of a team of doctors, scientists, engineers, and health industry experts, Curative began focusing on COVID-19 testing in early March 2020 upon realizing the urgent need for test development and production in the United States. Curative has a growing network of over 16,000 COVID-19 testing sites across 40 states and three CLIA certified, high-complexity labs.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Austin, United States
Sector
Fintech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Curative.

See all news

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A8 investors entered at this stage

  • DCVC
  • Soma Capital
  • Undeterred Capital
  • Refactor Capital
  • Martin Varsavsky
  • Mike Novogratz
  • Chris Anderson
  • Duquesne Family Office

Series B and later4 investors entered at this stage

  • Chris Anderson
  • Mike Novogratz
  • Duquesne Family Office
  • Martin Varsavsky
Team profiled 41 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States98.7%
🇮🇹 Italy0.2%
🇮🇳 India0.2%
🇪🇸 Spain0.2%
🇬🇧 United Kingdom0.2%
Top 5 of 9 shown
Web traffic by country
190K monthly visits
across markets
🇺🇸 United States94.3%
🇮🇳 India1.1%
🇨🇦 Canada0.8%
🇸🇬 Singapore0.6%
🇬🇧 United Kingdom0.6%
Top 5 markets shown

Patents

Estimated portfolio value
$18k

2 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Curative on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Curative on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.